Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

ADVA

Video

Takeda is not responsible for content provided by third parties

03 January 2023

Mosquito Longevity

VV-MEDMAT-62254

Related Topics:

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Mosquito Longevity

Dengue: Strategies to Limit Human Exposure to Disease-Carrying Mosquitos

Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia

Related Material